|
US6365787B1
(en)
|
1994-09-30 |
2002-04-02 |
The Johns Hopkins University |
Compounds for the suppression of HIV TAT transactivation
|
|
KR100645448B1
(ko)
*
|
1996-11-20 |
2006-11-13 |
예일 유니버시티 |
세포 아폽토시스를 저해하는 설바이빈 단백질 및 이를 조절하는 방법
|
|
US7226730B1
(en)
*
|
1997-02-26 |
2007-06-05 |
The General Hospital Corporation |
Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of Alzheimer's Disease
|
|
EP0975651A4
(en)
*
|
1997-02-26 |
2005-03-09 |
Gen Hospital Corp |
TRANSGENIC ANIMALS AND CELL LINES FOR THE DETECTION OF MEDICAMENTS EFFECTIVE FOR THE TREATMENT OR PREVENTION OF ALZHEIMER'S DISEASE
|
|
US20030033621A1
(en)
*
|
1997-02-26 |
2003-02-13 |
De La Monte Suzanne |
Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of Alzheimer's disease
|
|
EP1066527A2
(en)
*
|
1998-04-01 |
2001-01-10 |
Yale University |
Method to identify modulators of survivin - tubulin interaction
|
|
AU4990999A
(en)
*
|
1998-07-14 |
2000-02-07 |
Jenner Biotherapies, Inc. |
Survivin, and peptides thereof, as an anti-cancer vaccine
|
|
US6077709A
(en)
*
|
1998-09-29 |
2000-06-20 |
Isis Pharmaceuticals Inc. |
Antisense modulation of Survivin expression
|
|
US6335194B1
(en)
*
|
1998-09-29 |
2002-01-01 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of survivin expression
|
|
US6838283B2
(en)
|
1998-09-29 |
2005-01-04 |
Isis Pharmaceuticals Inc. |
Antisense modulation of survivin expression
|
|
AU2003205017B2
(en)
*
|
1998-09-29 |
2005-12-15 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of survivin expression
|
|
US6773911B1
(en)
|
1998-11-23 |
2004-08-10 |
Amgen Canada Inc. |
Apoptosis-inducing factor
|
|
US6608108B2
(en)
*
|
1999-10-15 |
2003-08-19 |
Johns Hopkins University |
Method for treatment of tumors using nordihydroguaiaretic acid derivatives
|
|
EP3225632B1
(en)
|
1999-11-30 |
2020-05-06 |
Mayo Foundation for Medical Education and Research |
Antibodies binding to b7-h1, a novel immunoregulatory molecule
|
|
CA2383001A1
(en)
|
1999-12-10 |
2001-06-14 |
Anticancer, Inc. |
Methods for introducing genes into mammalian subjects
|
|
US6509162B1
(en)
*
|
2000-02-29 |
2003-01-21 |
Yale University |
Methods for selectively modulating survivin apoptosis pathways
|
|
AU2001273102A1
(en)
*
|
2000-06-29 |
2002-01-14 |
The Salk Institute For Biological Studies |
Crystal structure of survivin
|
|
US7776518B2
(en)
|
2001-01-12 |
2010-08-17 |
Yale University |
Detection of survivin in the biological fluids of cancer patients
|
|
US7097966B2
(en)
|
2001-01-12 |
2006-08-29 |
Yale University |
Detection of survivin in the biological fluids of cancer patients
|
|
DE10102722A1
(de)
*
|
2001-01-22 |
2002-08-14 |
Medinnova Ges Med Innovationen |
Verfahren und Testsystem zum Auffinden von Nervenzell-schützenden Substanzen
|
|
WO2003061519A2
(en)
*
|
2002-01-18 |
2003-07-31 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for preserving the viability of photoreceptor cells
|
|
US7892559B2
(en)
|
2002-01-30 |
2011-02-22 |
Survac Aps |
Survivin-derived peptides and use thereof
|
|
US20040210035A1
(en)
*
|
2002-01-30 |
2004-10-21 |
Straten Eivind Per Thor |
Survivin-derived peptides and use thereof
|
|
US7332580B2
(en)
*
|
2002-04-05 |
2008-02-19 |
The Regents Of The University Of California |
Bispecific single chain Fv antibody molecules and methods of use thereof
|
|
US7332585B2
(en)
*
|
2002-04-05 |
2008-02-19 |
The Regents Of The California University |
Bispecific single chain Fv antibody molecules and methods of use thereof
|
|
US20040102395A1
(en)
*
|
2002-11-22 |
2004-05-27 |
Isis Pharmaceuticals Inc. |
Modulation of IAP-like expression
|
|
WO2004046386A1
(en)
|
2002-11-15 |
2004-06-03 |
Genomic Health, Inc. |
Gene expression profiling of egfr positive cancer
|
|
CA2450643A1
(en)
*
|
2002-12-24 |
2004-04-30 |
Northern Therapeutics Inc. |
Methods of diagnosing, preventing, and treating early onset of pulmonary hypertension
|
|
US20040231909A1
(en)
|
2003-01-15 |
2004-11-25 |
Tai-Yang Luh |
Motorized vehicle having forward and backward differential structure
|
|
PT2359841E
(pt)
*
|
2003-01-30 |
2015-02-10 |
Survac Aps |
Péptidos derivados de survivina e a sua utilização
|
|
AU2004211955B2
(en)
*
|
2003-02-06 |
2009-05-14 |
Cedars-Sinai Medical Center |
Gene expression markers for response to EGFR inhibitor drugs
|
|
US7713738B2
(en)
|
2003-02-10 |
2010-05-11 |
Enzon Pharmaceuticals, Inc. |
Oligomeric compounds for the modulation of survivin expression
|
|
US7767391B2
(en)
*
|
2003-02-20 |
2010-08-03 |
Genomic Health, Inc. |
Use of intronic RNA to measure gene expression
|
|
KR101199789B1
(ko)
*
|
2003-03-24 |
2012-11-09 |
더 스크립스 리서치 인스티튜트 |
종양 성장 억제 ｄｎａ 백신
|
|
JP2007506442A
(ja)
*
|
2003-05-30 |
2007-03-22 |
ゲノミック ヘルス， インコーポレイテッド |
Ｅｇｆｒ阻害薬への応答に関する遺伝子発現マーカー
|
|
BRPI0410886A
(pt)
*
|
2003-06-03 |
2006-07-04 |
Isis Pharmaceuticals Inc |
composto de filamento duplo, composição farmacêutica, sal farmaceuticamente aceitável, métodos de modificação do ácido nucleico que codifica a survivina humana, de inibição da expressão da suvivina em células ou tecidos, e de tratamento de uma condição associada com a expressão ou superexpressão da suvivina, e, oligonucleotìdeo de rnai de filamento único
|
|
DK1641810T4
(en)
|
2003-06-24 |
2017-07-03 |
Genomic Health Inc |
Predicting the likelihood of cancer recurrence
|
|
ES2905579T3
(es)
*
|
2003-07-10 |
2022-04-11 |
Genomic Health Inc |
Algoritmo del perfil de expresión y prueba para el pronóstico de la recaída del cáncer de mama
|
|
AU2004284434A1
(en)
*
|
2003-10-16 |
2005-05-06 |
Genomic Health, Inc. |
qRT-PCR assay system for gene expression profiling
|
|
US7842294B2
(en)
|
2003-11-19 |
2010-11-30 |
Survac Aps |
Proteins belonging to the Bcl-2 family and fragments thereof, and their use in cancer patients
|
|
EP1699936B1
(en)
*
|
2003-12-23 |
2011-02-09 |
Genomic Health, Inc. |
Universal amplification of fragmented rna
|
|
EP1737980A2
(en)
|
2004-04-09 |
2007-01-03 |
Fondazione IRCCS Istituto Nazionale dei Tumori |
Gene expression markers for predicting response to chemotherapy
|
|
US20050260659A1
(en)
*
|
2004-04-23 |
2005-11-24 |
Exagen Diagnostics, Inc. |
Compositions and methods for breast cancer prognosis
|
|
US7342093B2
(en)
*
|
2004-07-23 |
2008-03-11 |
University Of Massachusetts |
Compounds that inhibit Hsp90 protein-protein interactions with IAP proteins
|
|
WO2006042237A2
(en)
|
2004-10-06 |
2006-04-20 |
Mayo Foundation For Medical Education And Research |
B7-h1 and methods of diagnosis, prognosis, and treatment of cancer
|
|
WO2006052731A2
(en)
*
|
2004-11-05 |
2006-05-18 |
Genomic Health, Inc. |
Molecular indicators of breast cancer prognosis and prediction of treatment response
|
|
CA2585571C
(en)
|
2004-11-05 |
2020-01-21 |
Genomic Health, Inc. |
Predicting response to chemotherapy using gene expression markers
|
|
EP1824975B9
(en)
|
2004-11-09 |
2011-04-20 |
Santaris Pharma A/S |
Lna oligonucleotides and the treatment of cancer
|
|
WO2006051075A1
(en)
|
2004-11-12 |
2006-05-18 |
Vib Vzw |
Use of survivin to treat kidney failure
|
|
MX2007007624A
(es)
*
|
2004-12-22 |
2007-08-03 |
Gillette Co |
Reduccion del crecimiento del pelo con inhibidores de survivina.
|
|
CA2593714C
(en)
|
2005-02-04 |
2013-09-10 |
Survac Aps |
Survivin peptide vaccine
|
|
US7803375B2
(en)
*
|
2005-02-23 |
2010-09-28 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for treating conditions of the eye
|
|
US20060276423A1
(en)
*
|
2005-04-18 |
2006-12-07 |
Rachel Altura |
Survivin-directed RNA interference-compositions and methods
|
|
PL1889065T3
(pl)
|
2005-05-18 |
2013-12-31 |
Novartis Ag |
Metody diagnostyki i leczenia chorób posiadających składnik autoimmunologiczny i/lub zapalny
|
|
US7272013B1
(en)
*
|
2005-07-28 |
2007-09-18 |
American Megatrends, Inc. |
Interchangeable design support system
|
|
WO2007019427A2
(en)
*
|
2005-08-08 |
2007-02-15 |
Massachusetts Eye & Ear Infirmary |
Methods and compositions for preserving the viability of photoreceptor cells
|
|
US20070049752A1
(en)
*
|
2005-08-23 |
2007-03-01 |
Drysdale Neville E |
Preparation of 2,6-dioxa-7-aza-bicyclo[2.2.2] octanes
|
|
US7812173B2
(en)
*
|
2005-08-23 |
2010-10-12 |
E.I. Du Pont De Nemours And Company |
Tetrahydro-1,8-dioxa-4a-aza-naphthalenes in coating applications
|
|
US20070104689A1
(en)
*
|
2005-09-27 |
2007-05-10 |
Merck Patent Gmbh |
Compositions and methods for treating tumors presenting survivin antigens
|
|
WO2007082154A2
(en)
*
|
2006-01-05 |
2007-07-19 |
Mayo Foundation For Medical Education And Research |
B7-h1 and b7-h4 in cancer
|
|
WO2007082144A2
(en)
*
|
2006-01-05 |
2007-07-19 |
Mayo Foundation For Medical Education And Research |
B7-h1 and survivin in cancer
|
|
WO2007124361A2
(en)
*
|
2006-04-20 |
2007-11-01 |
Mayo Foundation For Medical Education And Research |
Soluble b7-h1
|
|
US8580263B2
(en)
*
|
2006-11-21 |
2013-11-12 |
The Regents Of The University Of California |
Anti-EGFR family antibodies, bispecific anti-EGFR family antibodies and methods of use thereof
|
|
US8002827B2
(en)
*
|
2007-04-24 |
2011-08-23 |
Abbott Medical Optics Inc. |
Systems and methods for ocular measurements
|
|
US9216080B2
(en)
|
2007-08-27 |
2015-12-22 |
Amo Groningen B.V. |
Toric lens with decreased sensitivity to cylinder power and rotation and method of using the same
|
|
US8974526B2
(en)
|
2007-08-27 |
2015-03-10 |
Amo Groningen B.V. |
Multizonal lens with extended depth of focus
|
|
JP2011501731A
(ja)
|
2007-09-10 |
2011-01-13 |
ユニバーシティ オブ マサチューセッツ |
ミトコンドリア標的化抗腫瘍剤
|
|
WO2009101202A1
(en)
|
2008-02-15 |
2009-08-20 |
Amo Regional Holdings |
System, ophthalmic lens, and method for extending depth of focus
|
|
US8439498B2
(en)
|
2008-02-21 |
2013-05-14 |
Abbott Medical Optics Inc. |
Toric intraocular lens with modified power characteristics
|
|
US20110020325A1
(en)
*
|
2008-02-29 |
2011-01-27 |
Kwon Eugene D |
Methods for reducing granulomatous inflammation
|
|
JP5546448B2
(ja)
|
2008-03-31 |
2014-07-09 |
株式会社バイオイミュランス |
ＭＨＣクラスＩＩ分子に提示されるサーバイビン（Ｓｕｒｖｉｖｉｎ）の部分ペプチドとその利用法
|
|
US8862447B2
(en)
|
2010-04-30 |
2014-10-14 |
Amo Groningen B.V. |
Apparatus, system and method for predictive modeling to design, evaluate and optimize ophthalmic lenses
|
|
US8480228B2
(en)
|
2009-12-18 |
2013-07-09 |
Amo Groningen B.V. |
Limited echelette lens, systems and methods
|
|
EP2560629B1
(en)
|
2010-04-23 |
2020-06-03 |
Massachusetts Eye & Ear Infirmary |
Methods and compositions for preserving photoreceptor and retinal pigment epithelial cells
|
|
WO2012061045A2
(en)
|
2010-11-01 |
2012-05-10 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for preserving retinal ganglion cells
|
|
AU2011336183B2
(en)
|
2010-12-01 |
2015-07-16 |
Amo Groningen B.V. |
A multifocal lens having an optical add power progression, and a system and method of providing same
|
|
CA2888805C
(en)
|
2011-10-21 |
2020-07-14 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for promoting axon regeneration and nerve function
|
|
AU2013353764B2
(en)
|
2012-12-04 |
2018-12-06 |
Amo Groningen B.V. |
Lenses systems and methods for providing binocular customized treatments to correct presbyopia
|
|
US9302005B2
(en)
|
2013-03-14 |
2016-04-05 |
Mayo Foundation For Medical Education And Research |
Methods and materials for treating cancer
|
|
CA2908042C
(en)
|
2013-03-27 |
2023-01-31 |
Immunovaccine Technologies Inc. |
Method for improving the efficacy of a survivin vaccine in the treatment of cancer
|
|
EP3052131B1
(en)
|
2013-10-01 |
2018-12-05 |
Mayo Foundation for Medical Education and Research |
Methods for treating cancer in patients with elevated levels of bim
|
|
AU2014365888B2
(en)
*
|
2013-12-16 |
2018-12-06 |
Merck Patent Gmbh |
Survivin-directed cancer vaccine therapy
|
|
US10302653B2
(en)
|
2014-05-22 |
2019-05-28 |
Mayo Foundation For Medical Education And Research |
Distinguishing antagonistic and agonistic anti B7-H1 antibodies
|
|
WO2016014148A1
(en)
|
2014-07-23 |
2016-01-28 |
Mayo Foundation For Medical Education And Research |
Targeting dna-pkcs and b7-h1 to treat cancer
|
|
WO2016109880A1
(en)
|
2015-01-06 |
2016-07-14 |
Immunovaccine Technologies Inc. |
Lipid a mimics, methods of preparation, and uses thereof
|
|
WO2016179573A1
(en)
*
|
2015-05-07 |
2016-11-10 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Variant survivin vaccine for treatment of cancer
|
|
AU2016318158B2
(en)
*
|
2015-09-04 |
2022-09-15 |
Health Research, Inc. |
Anti-survivin antibodies for cancer therapy
|
|
WO2017075045A2
(en)
|
2015-10-30 |
2017-05-04 |
Mayo Foundation For Medical Education And Research |
Antibodies to b7-h1
|
|
CN108430505A
(zh)
|
2015-11-18 |
2018-08-21 |
免疫疫苗技术有限公司 |
包括聚肌胞苷酸多核苷酸佐剂和基于脂质的佐剂的辅助系统以及无水疫苗组合物
|
|
CA3013857A1
(en)
|
2016-02-09 |
2017-08-17 |
Amo Groningen B.V. |
Progressive power intraocular lens, and methods of use and manufacture
|
|
WO2017165660A1
(en)
|
2016-03-23 |
2017-09-28 |
Abbott Medical Optics Inc. |
Ophthalmic apparatus with corrective meridians having extended tolerance band
|
|
CA3018570A1
(en)
|
2016-03-23 |
2017-09-28 |
Johnson & Johnson Surgical Vision, Inc. |
Ophthalmic apparatus with corrective meridians having extended tolerance band
|
|
US11060087B2
(en)
*
|
2016-06-15 |
2021-07-13 |
The Regents Of The University Of California |
Synthetic promoters for high throughput screening and gene modulation
|
|
EP3522771B1
(en)
|
2016-10-25 |
2022-04-06 |
Amo Groningen B.V. |
Realistic eye models to design and evaluate intraocular lenses for a large field of view
|
|
US10739227B2
(en)
|
2017-03-23 |
2020-08-11 |
Johnson & Johnson Surgical Vision, Inc. |
Methods and systems for measuring image quality
|
|
WO2019106067A1
(en)
|
2017-11-30 |
2019-06-06 |
Amo Groningen B.V. |
Intraocular lenses that improve post-surgical spectacle independent and methods of manufacturing thereof
|
|
FR3087448B1
(fr)
|
2018-10-23 |
2023-10-13 |
Pdc Line Pharma |
Lignee pdc modifiee pour secreter une cytokine
|
|
US12257286B2
(en)
|
2018-10-31 |
2025-03-25 |
Mayo Foundation For Medical Education And Research |
Methods and materials for treating cancer
|
|
WO2020092839A1
(en)
|
2018-10-31 |
2020-05-07 |
Mayo Foundation For Medical Education And Research |
Methods and materials for treating cancer
|
|
US11886046B2
(en)
|
2019-12-30 |
2024-01-30 |
Amo Groningen B.V. |
Multi-region refractive lenses for vision treatment
|
|
WO2022233683A1
(en)
|
2021-05-05 |
2022-11-10 |
Amo Groningen B.V. |
Ring halometer system and method for quantifying dysphotopsias
|
|
US12544218B2
(en)
|
2021-12-03 |
2026-02-10 |
Amo Groningen B.V. |
Lenses having multi-ring design for vision treatment
|